MARTELLI, Massimo Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 10.570
EU - Europa 6.797
AS - Asia 5.793
SA - Sud America 963
Continente sconosciuto - Info sul continente non disponibili 503
AF - Africa 156
OC - Oceania 5
Totale 24.787
Nazione #
US - Stati Uniti d'America 10.127
SG - Singapore 2.669
UA - Ucraina 1.149
IE - Irlanda 1.062
IT - Italia 920
SE - Svezia 862
CN - Cina 804
RU - Federazione Russa 797
BR - Brasile 718
HK - Hong Kong 716
VN - Vietnam 564
DE - Germania 529
FI - Finlandia 419
FR - Francia 336
GB - Regno Unito 298
KR - Corea 294
CA - Canada 200
IN - India 136
BD - Bangladesh 100
TR - Turchia 91
AR - Argentina 87
IQ - Iraq 66
BE - Belgio 61
MX - Messico 56
PL - Polonia 55
NL - Olanda 53
ZA - Sudafrica 49
UZ - Uzbekistan 46
JP - Giappone 45
AT - Austria 44
CO - Colombia 41
CZ - Repubblica Ceca 41
CR - Costa Rica 38
PK - Pakistan 38
EC - Ecuador 33
CH - Svizzera 29
ES - Italia 29
ID - Indonesia 28
SA - Arabia Saudita 27
VE - Venezuela 27
GT - Guatemala 26
TT - Trinidad e Tobago 22
HN - Honduras 21
JO - Giordania 21
MA - Marocco 19
CW - ???statistics.table.value.countryCode.CW??? 18
JM - Giamaica 18
LT - Lituania 18
PH - Filippine 18
RO - Romania 18
CL - Cile 17
GR - Grecia 16
IL - Israele 16
BO - Bolivia 15
KE - Kenya 15
LB - Libano 14
PY - Paraguay 14
NI - Nicaragua 13
DZ - Algeria 12
EG - Egitto 12
MY - Malesia 12
TN - Tunisia 12
SV - El Salvador 11
GP - Guadalupe 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
ET - Etiopia 9
OM - Oman 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
BG - Bulgaria 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
EE - Estonia 7
EU - Europa 7
NP - Nepal 7
PR - Porto Rico 6
PT - Portogallo 6
SC - Seychelles 6
KG - Kirghizistan 5
PE - Perù 5
AM - Armenia 4
AU - Australia 4
GE - Georgia 4
HR - Croazia 4
RS - Serbia 4
SI - Slovenia 4
KW - Kuwait 3
MM - Myanmar 3
PA - Panama 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
BZ - Belize 2
GD - Grenada 2
GY - Guiana 2
Totale 24.257
Città #
Singapore 1.867
Chandler 1.232
Dublin 1.062
San Jose 890
Ashburn 787
Hong Kong 711
San Mateo 670
Jacksonville 636
Boardman 396
Santa Clara 354
Council Bluffs 322
Ann Arbor 304
Seoul 288
Moscow 248
Princeton 236
Medford 226
Beijing 221
Dong Ket 215
Lauterbourg 199
Altamura 191
Perugia 176
Wilmington 166
Los Angeles 164
Andover 161
New York 159
Munich 152
Lawrence 140
Piscataway 125
Helsinki 115
Ho Chi Minh City 105
Dallas 85
The Dalles 80
Turku 80
São Paulo 70
Hanoi 65
Woodbridge 63
Saint Petersburg 62
Brussels 58
Norwalk 54
Orem 54
Milan 52
Montreal 52
Frankfurt am Main 47
Houston 47
Shanghai 47
Tokyo 43
Des Moines 42
London 42
Rome 42
Phoenix 41
Atlanta 36
Brooklyn 36
Dearborn 34
Izmir 33
Denver 32
San Paolo di Civitate 32
Stockholm 31
Toronto 31
Warsaw 31
Chicago 30
Johannesburg 30
San José 29
North Bergen 28
Amsterdam 27
Baghdad 27
Auburn Hills 26
Falkenstein 25
Chennai 24
Rio de Janeiro 24
Bologna 23
Brno 23
Charlotte 23
San Francisco 23
Boston 20
Guatemala City 20
Redwood City 20
Tashkent 20
Nuremberg 19
San Diego 19
Florence 18
Mexico City 18
Da Nang 17
Foligno 17
Quito 17
Amman 16
Brasília 16
Naples 16
Willemstad 16
Ankara 15
Belo Horizonte 15
Hefei 15
Manchester 15
Lahore 14
Guangzhou 13
Nairobi 13
New Delhi 13
Ottawa 13
Poplar 13
Buenos Aires 12
Buffalo 12
Totale 14.734
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 194
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 193
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 180
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 172
Innate immunity against hematological malignancies 169
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 167
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 163
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 161
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 160
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 156
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 154
A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma 154
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 153
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 152
14q+ chromosome marker in a T-cell-rich B-cell lymphoma. 151
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 151
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 150
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 149
Graft engineering for allogeneic haploidentical stem cell transplantation 146
Fourth international workshop on haploidentical transplants, Naples, Italy 144
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 142
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 141
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 138
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 138
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 137
Acute lymphoblastic leukaemia in Noonan syndrome 137
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 137
5q- syndrome termi¬nating in acute myeloid leukemia: karyotype evolution and immunological characterization of blast cells. 135
3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. 134
"Designed" grafts for HLA-haploidentical stem cell transplantation. 134
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 133
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia 133
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 133
Mesenchymal cells: a vehicle for gene therapy 132
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 132
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 131
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 130
A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement 130
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 130
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 130
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 130
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 130
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 130
5q- syndrome in a patient with chronic exposure to ionizing radiation. 128
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 128
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 128
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 126
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 126
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 124
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 124
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 123
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases 123
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 123
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 122
Transplants across human leukocyte antigen barriers 122
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 122
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 122
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 122
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 121
Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies 121
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 120
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 120
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 119
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 119
T regulatory cell separation for clinical application. 118
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 117
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 117
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 116
Decreased bone mineral density after autologous stem cell transplantation. 115
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells 115
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 115
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 115
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 114
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 114
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 114
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 113
Allogeneic transplantation across the HLA barriers. 113
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 112
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene 112
. Mismatched hematopoietic stem cell transplants in elderly patients. 112
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 111
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 111
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia 111
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 110
AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer 110
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 110
Natural killer cell alloreactivity for leukemia therapy. 110
The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects 109
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 109
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 109
Submicroscopic deletions in 5q- associated malignancies 109
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 109
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 108
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 108
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 107
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 107
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 107
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 107
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 107
Total Marrow/Total Lymphoid Irradiation as Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 107
Totale 12.887
Categoria #
all - tutte 107.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.343 0 0 0 0 94 11 30 620 18 39 266 265
2022/20233.658 253 631 26 336 276 384 4 200 1.391 12 113 32
2023/20241.503 85 156 64 31 10 20 320 43 197 40 251 286
2024/20253.323 93 347 136 156 446 144 91 251 619 185 565 290
2025/20267.350 535 476 336 974 1.056 728 1.181 371 823 648 159 63
2026/20272.241 122 250 416 1.243 210 0 0 0 0 0 0 0
Totale 24.787